Glycyl-glutamine, an endogenous β-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 2, 2005, Pages 949-958

  Cavun, Sinan ^a,c   Göktalay, Gökhan ^a,b   Millington, William R ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b Ion Technologies Inc   (United States)

^c ULUDAG UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN DERIVATIVE; GLYCYLGLUTAMINE; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONDITIONING; CONTROLLED STUDY; DRUG PELLET; DRUG SENSITIVITY; DRUG WITHDRAWAL; FOOD PREFERENCE; MALE; MORPHINE ADDICTION; MORPHINE TOLERANCE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; TAIL FLICK TEST; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; BETA-ENDORPHIN; CONDITIONING, OPERANT; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG TOLERANCE; FOOD; INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; REINFORCEMENT (PSYCHOLOGY); SUBSTANCE WITHDRAWAL SYNDROME;

EID: 27144518063     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.091553     Document Type: Article

References (39)

1. Bailey CP and Connor M (2005) Opioids: cellular mechanisms of tolerance and physical dependence. Curr Opin Pharmacol 5:60-68.
2. Bals-Kubik R, Herz A, and Shippenberg TS (1988) β-Endorphin-(1-27) is a naturally occurring antagonist of the reinforcing effects of opioids. Naunyn-Schmiedeberg's Arch Pharmacol 338:392-396.
3. Berglund LA, Millington WR, and Simpkins JW (1989) Gonadal steroid and chronic morphine treatment do not change the post-translational processing of β-endorphin in rat brain. Life Sci 44:591-601.
4. Bronstein DM, Przewlocki R, and Akil H (1990) Effects of morphine treatment on pro-opiomelanocortin systems in rat brain. Brain Res 519:102-111.
5. Chen JC, Tao PL, Li JY, Wong CH, and Huang EY (2003) Endomorphin-1 and -2 induce naloxone-precipitated withdrawal syndromes in rats. Peptides 24:477-481.
6. Cicero TJ and Meyer ER (1973) Morphine pellet implantation in rats: quantitative assessment of tolerance and dependence. J Pharmacol Exp Ther 184:404-408.
7. Deakin JF, Doströvsky JO, and Smyth DG (1980) Influence of N-terminal acetylation and C-terminal proteolysis on the analgesic activity of β-endorphin. Biochem J 189:501-506.
8. Dores RM, Jain M, and Akil H (1986) Characterization of the forms of betaendorphin and alpha-MSH in the caudal medulla of the rat and guinea pig. Brain Res 377:251-260.
9. Gellert VF and Holtzman SG (1978) Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions. J Pharmacol Exp Ther 205:536-546.
10. González P, Cabello P, Germany A, Norris B, and Contreras E (1997) Decrease of tolerance to and physical dependence on, morphine by glutamate receptor antagonists. Eur J Pharmacol 332:257-262.
11. Hirsch MD and O'Donohue TL (1986) Structural modifications of pro-opiomelanocortin-derived peptides alter their behavioral effects markedly. J Pharmacol Exp Ther 237:378-385.
12. Koelle GB, Massoulie J, Eugene D, and Melone MA (1988) Effects of glycyl-Lglutamine in vitro on the molecular forms of acetylcholinesterase in the preganglionically denervated superior cervical ganglion of the cat. Proc Natl Acad Sci USA 85:1686-1690.
13. Kolesnikov YA, Maccechini ML, and Pasternak GW (1994) 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance. Life Sci 55:1393-1398.
14. Koob GF and Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science (Wash DC) 278:52-58.
15. 12 acetylcholinesterase but not of nicotine acetylcholine receptors in quail embryonic myotubes by a cyclic AMP-independent mechanism. J Neurochem 54:1122-1129.
16. McCain HW, Bilotta J, and Lamster IB (1987) Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine. Life Sci 41:169-176.
17. Mucha RF and Walker MJK (1987) Aversive property of opioid receptor blockade in drug-naive mice. Psychopharmacology 93:483-488.
18. Nicolas P and Li CH (1985) -Endorphin-(1-27) is a naturally occurring antagonist to etorphine-induced analgesia. Proc Natl Acad Sci USA 82:3178-3181.
19. Nores WL, Olson RD, Olson GA, Vaccarino AL, Bell RL, Zadina JE, and Kastin AJ (1999) Tyr-W-MIF-1-induced conditioned place preference. Peptides 20:479-484.
20. Ossipov MH, Lai J, King T, Vanderah TW, Malan TP, Hruby VJ, and Porreca F (2004) Antinociceptive and nociceptive actions of opioids. J Neurobiol 61:126-148.
21. Owen MD, Unal CB, Callahan MF, Triveda K, York C, and Millington WR (2000) Glycyl-glutamine inhibits the respiratory depression, but not the antinociception, produced by morphine. Am J Physiol 279:R1944-R1948.
22. Parish DC, Smyth DG, Normanton JR, and Wolstencroft JH (1983) Glycyl glutamine, an inhibitory neuropeptide derived from β-endorphin. Nature (Lond) 306:267-270.
23. Raffin-Sanson ML, de Keyzer Y, and Bertagna X (2003) Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions. Eur J Endocrinol 149:79-90.
24. Reid LD, Marglin SH, Mattie ME, and Hubbell CL (1989) Measuring morphine's capacity to establish a place preference. Pharmacol Biochem Behav 33:765-775.
25. Schulteis G, Markou A, Gold LH, Stinus L, and Koob GF (1994) Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther 271:1391-1398.
26. Skoubis PD, Lam HA, Shoblock J, Narayanan S, and Maidment NT (2005) Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur J Neurosci 21:1379-1384.
27. Slusher BS, Thomas A, Paul M, Schad CA, and Ashby CR (2001) Expression and acquisition of the conditioned place preference response to cocaine in rats is blocked by selective inhibitors of the enzyme N-acetylated-α-linked- acidic dipeptidase (NAALADase). Synapse 41:22-28.
28. Smith AI and Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system and peripheral tissues. Endocr Rev 9:159-179.
29. Smith DJ, Robertson B, Monroe PJ, Taylor DA, Leedham JA, and Cabral JDY (1992) Opioid receptors mediating antinociception from β-endorphin and morphine in the periaqueductal gray. Neuropharmacology 31:1137-1150.
30. Spanagel R, Herz A, and Shippenberg TS (1991) Modulation of the mesolimbic dopaminergic system by β-endorphin-(1-27) as assessed by microdialysis. Eur J Pharmacol 200:319-324.
31. Trujillo KA (2000) Are NMDA receptors involved in opiate-induced neural and behavioral plasticity? A review of preclinical studies. Psychopharmacology 151:121-141.
32. Tseng LF (2001) Evidence for ε-opioid receptor-mediated β-endorphin-induced analgesia. Trends Pharmacol Sci 22:623-630.
33. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56:613-672.
34. Tzschentke TM and Schmidt WJ (1997) Interactions of MK-801 and GYKI 52466 with morphine and amphetamine in place preference conditioning and behavioral sensitization. Behav Brain Res 84:99-107.
35. Unal CB, Owen MD, and Millington WR (1994) Inhibition of β-endorphin-induced cardiorespiratory depression by glycyl-L-glutamine, a dipeptide derived from β-endorphin processing. J Pharmacol Exp Ther 271:952-958.
36. Unal CB, Owen MD, and Millington WR (1997) Cyclo(Gly-Gln) inhibits the cardiorespiratory depression produced by β-endorphin and morphine. Brain Res 747:52-59.
37. White NM (1996) Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91:921-949.
38. Witkin JM, Steele TD, and Sharpe LG (1997) Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J Pharmacol Exp Ther 280:46-52.
39. Zakarian S and Smyth DG (1982) Distribution of -endorphin-related peptides in rat pituitary and brain. Biochem J 202:561-571.